Icon
+91 94997 68112
Login Register

GRALISE (nda022544)- (300MG,450MG,600MG,750MG,900MG)

GABAPENTIN ALMATICA
300MG,450MG,600MG,750MG,900MG
Yes Yes
Expired Expired
None None
None No
GRALISE is indicated for the management of Postherpetic Neuralgia (PHN).
3 1 3
Total Other Developers 2
Drugs with Suitability No
300MG ** ** - - 1
450MG ** ** - - -
600MG ** ** - - 2
750MG ** ** - - -
900MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ********* **** ******, *** *********** ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) ***
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.